Incidence of Peripheral Neuropathy in Elderly Patients with Metastatic Breast Cancer Receiving Eribulin (Eri) or Ixabepilone (Ixa) Chemotherapy

被引:0
|
作者
Lee, L. [1 ]
Vahdat, L. [1 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:S176 / S177
页数:2
相关论文
共 50 条
  • [41] Incidence and severity of chemotherapy induced peripheral neuropathy in geriatric population who are receiving chemotherapy
    Mandepudi, A.
    Paibhavi, P. R.
    Maka, V. V.
    Reddy, H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] Survival of metastatic metaplastic breast cancer patients receiving chemotherapy.
    Kukunoor, Sparsha
    Lee, Anna
    Taiwo, Evelyn Oluwatoyin
    Schreiber, David
    Luhrs, Carol A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] Eribulin patients with metastatic breast cancer in clinical practice
    Poggio, F.
    Lambertini, M. L. Matteo
    D'Alonzo, A. D. Alessia
    Levaggi, A. L. Alessia
    Giraudi, S. G. Sara
    Bighin, C. B. Claudia
    Iacono, G. I. Giuseppina
    Pronzato, P. P. Paolo
    Del Mastro, L. D. M. Lucia
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S183 - S183
  • [44] Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
    Argyriou, Andreas A.
    Polychronopoulos, Panagiotis
    Iconomou, Gregoris
    Koutras, Angelos
    Makatsoris, Thomas
    Gerolymos, Miltiadis K.
    Gourzis, Philippos
    Assimakopoulos, Konstantinos
    Kalofonos, Haralabos P.
    Chroni, Elisabeth
    ACTA ONCOLOGICA, 2007, 46 (08) : 1131 - 1137
  • [45] INCIDENCE OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS IN CLINICAL PRACTICE
    Mazilu, Laura
    Stanculeanu, Dana-Lucia
    Gheorghe, Andreea-Daniela
    Voinea, Felix
    Suceveanu, Adrian-Paul
    Pituru, Silviu
    Diaconu, Camelia Cristina
    Parepa, Irinel-Raluca
    Stoian, Anca Pantea
    Pop, Corina Silvia
    Suceveanu, Andra-Iulia
    FARMACIA, 2019, 67 (03) : 472 - 476
  • [46] Eribulin for the treatment of metastatic breast cancer: a top of the table chemotherapy option?
    Twelves, Chris
    BREAST CANCER MANAGEMENT, 2014, 3 (06) : 459 - 463
  • [47] PAINTER: Evaluation of eribulin tolerability and correlation between a set of polymorphisms and neuropathy in patients with metastatic breast cancer
    La Verde, N.
    Moretti, A.
    Damia, G.
    Paterno, E.
    Santini, D.
    Garrone, O.
    Fabi, A.
    Ciccarese, M.
    Cretella, E.
    Torri, V.
    Generali, D.
    Grasso, D.
    Puglisi, F.
    Collova, E.
    Roila, F.
    Bertolini, A.
    Barni, S.
    Vici, P.
    Luigi, C.
    Scandurra, G.
    Bramati, A.
    Dazzani, M. C.
    Farina, G.
    CANCER RESEARCH, 2017, 77
  • [48] Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
    Simsek, Neriman Yukselturk
    Demir, Ayten
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2018, 5 (04) : 435 - 441
  • [49] Peripheral Neuropathy in Patients With Gynecologic Cancer Receiving Chemotherapy: Patient Reports and Provider Assessments
    Kiser, DeLeslie W.
    Greer, Tara B.
    Wilmoth, Margaret C.
    Dmochowski, Jacek
    Naumann, R. Wendel
    ONCOLOGY NURSING FORUM, 2010, 37 (06) : 758 - 764
  • [50] Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study
    Junji Tsurutani
    Yukinori Sakata
    Toshiyuki Matsuoka
    Breast Cancer, 2019, 26 : 235 - 243